Cunningham Timothy M. 4
4 · Organogenesis Holdings Inc. · Filed Apr 24, 2020
Insider Transaction Report
Form 4
Cunningham Timothy M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-22+183,424→ 183,424 totalExercise: $4.04Exp: 2030-04-22→ Class A Common Stock (183,424 underlying) - Award
Class A Common Stock
2020-04-22+27,847→ 27,847 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning April 1, 2020.
- [F2]The option becomes exercisable in equal annual installments over four years beginning April 1, 2020.